The study reported the results of a two-year follow-up study of PDT treatments in 38 eyes of 38 PCV patients. Researchers measured visual acuity and optical coherence tomography every 3 months post-PDT procedure, and used angiography tests to evaluate vascular lesions.
Results showed the treatments were effective at improving visual acuity through one year, and maintained the positive results at two years. The average number of treatments was 1.9, which the authors note is fewer than intravitreal injection of anti-vascular endothelial growth agents.
More Articles on Ophthalmology:
Study: Chemical in Rosemary May Help Macular Degeneration Patients
Harvard, Yale Have No Record of Dr. Salomon Melgen Attending, Despite His Claims
Ophthalmologist’s Office Raided Amid Sex, Fraud Scandal
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
